On August 8, 2017, the Office of Management and Budget approved a revised Federal Drug Testing Custody and Control Form (CCF) and authorized the continued use of the ‘old’ CCF until June 30, 2018.
What does this mean for the DOT drug testing program?
DOT regulated employers and their service agents (collectors, laboratories, Medical Review Officers) are to continue using the ‘old’ CCF until further notice from DOT’s Office of Drug and Alcohol Policy and Compliance. When using the 'old' CCF a "memorandum for the record" is not required.
How will I know the difference between the revised and ‘old’ CCF?
The ‘old’ CCF is the one that has been used under the DOT-regulated program since 2010.
The revised CCF includes the following changes:
- In Step 1D:
- Removal of the checkbox, the letters “DOT” and hash line in front of the text “Specify DOT Agency”
- In Step 5A:
- Addition of four new analytes (oxycodone, oxymorphone, hydrocodone, and hydromorphone),
- Removal of the analyte methylenedioxyethylamphetamine (MDEA).
Can DOT regulated employers and their service agents use the OMB approved revised CCF for testing under 49 CFR Part 40?
Not at this time because DOT has not issued a final rule authorizing testing for synthetic opioids. However, if the revised CCF is used inadvertently and the testing was consistent with Part 40, MROs are to verify and report the result according to Part 40.